Description / Scope of the Technical Need.
We are seeking existing and scalable solutions for innovative oral dosage forms that incorporate at least one API from our current portfolio across the various categories served by Opella: Allergy Relief, Cough &Cold, Digestive Wellness (including constipation relief, gut health/microbiome, acid control), Liver Care, Pain Management (oral and topical), and Physical & Mental Wellness (e.g. sleep, cognitive health, cardiovascular support, joint & bone health, immunity, energy, etc.) Your solution should be relevant to OTC products, medical devices, and/or food supplements, offering clear added value and superiority over traditional market options.
Key benefits to highlight include enhanced consumer experience, improved convenience, reduced posology, better adherence, superior bioavailability, and/or sustainability throughout the product lifecycle. Our goal is to support differentiated, premium products that stand out in the competitive OTC and food supplement markets while minimizing environmental impact.
Background.
At Opella, we are committed to empowering consumers to take control of their health. Premium and innovative oral dosage forms are transforming the way people manage their well-being by making self-care more accessible, convenient, and effective.
Key Success Criteria.
Must-have Requirements.
- Relevant to OTC products, medical devices, and/or food supplements, offering clear added value and superiority over traditional market options
- Incorporate at least one API from our current portfolio
- Ready or near to launch solutions
Preferred Requirements.
- Patented or proprietary technology
- First to market
Approaches not of interest.
- Generic products
- Format not compatible with the APIs in our portfolio
- Early-stage projects without proven stability, efficacy, scalability and manufacturing readiness
Target Group.
Adults and children, no specific health conditions
Geographies.
Global
Have a question or simply want to know more?
Any question or adverse reaction related to our products must be addressed via www.sanofi.com.